https://www.selleckchem.com/pr....oducts/JNJ-26481585.
36, 95% CI 1.04-1.77, P=.0277). Our main findings are that the occurrence of arterial hypertension G≥2 is a predictor of longer survival, whereas decreased appetite G≥2 predicts for a poor prognosis. A careful management of AEs under lenvatinib treatment for HCC is required, to improve patients' quality of life, minimize the need for treatment discontinuation and achieve optimal outcome. Our main findings are that the occurrence of arterial hypertension G ≥ 2 is a predictor of longer survival, whereas decreased appetite G ≥ 2 predi
پسندیدن
اظهار نظر
اشتراک گذاری
